DocMorris AG's gross profit for the
six
months ended in Jun. 2025 was CHF121 Mil. DocMorris AG's gross profit for the trailing twelve months (TTM) ended in Jun. 2025 was CHF230 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. DocMorris AG's gross profit for the
six
months ended in Jun. 2025 was CHF121 Mil. DocMorris AG's Revenue for the
six
months ended in Jun. 2025 was CHF541 Mil. Therefore, DocMorris AG's Gross Margin % for the quarter that ended in Jun. 2025 was 22.34%.
DocMorris AG had a gross margin of 22.34% for the quarter that ended in Jun. 2025 => Competition eroding margins
During the past 13 years, the highestGross Margin % of DocMorris AG was 21.68%. The lowest was 14.91%. And the median was 15.62%.
DocMorris AG (XSWX:DOCM) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
DocMorris AG had a gross margin of 22.34% for the quarter that ended in Jun. 2025 => Competition eroding margins
DocMorris AG Gross Profit Related Terms
DocMorris AG Gross Profit Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, DocMorris AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Gross Profit vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Gross Profit distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF230 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
DocMorris AG (XSWX:DOCM) has a Gross Profit of CHF230 Mil as of Jun. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on DocMorris AG and its competitors.
Is DocMorris AG's Gross Profit too high?
DocMorris AG's current Gross Profit is CHF230 Mil. Overall, DocMorris AG has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Gross Profit compare to competitors?
DocMorris AG's Gross Profit of CHF230 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Healthcare Providers & Services company?
A good Gross Profit depends on the Healthcare Providers & Services industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on DocMorris AG and its competitors. DocMorris AG's current Gross Profit is CHF230 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.54, compared to a current price of CHF9.13 — trading 13.4% below its estimated fair value. The current Gross Profit is CHF230 Mil. DocMorris AG's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Gross Profit is CHF230 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF9.13 is trading 13.4% below its estimated GF Value™ of CHF10.54.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
Gross Profit: CHF230 Mil
GF Value™: CHF10.54 vs. price of CHF9.13 (13.4% below fair value)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
66GF Score
Get the complete analysis for XSWX:DOCM
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
